Clinical application of the disposable incision retractor fixator in resection for papillary thyroid carcinoma
-
-
关键词:
- 甲状腺肿瘤 /
- 一次性切口牵开固定器 /
- 并发症
-
Key words:
- thyroid tumor /
- disposable incision retraction fixator /
- complication
-
-
表 1 两组患者一般临床资料
组别 例数 年龄/岁 性别 侧别 BMI 女 男 单 双 实验组 60 42.36±5.45 33 27 41 19 22.06±3.15 对照组 60 42.32±5.42 31 29 39 21 21.97±3.28 t/χ2 0.010 0.134 0.150 0.153 
下载: 导出CSV
表 2 两组患者手术指标比较
x±s 组别 例数 手术时间/min 出血量/mL 切口长度/cm 淋巴结数/枚 引流量/mL 住院时间/d 实验组 60 62.36±12.01 43.0±7.10 5.57±1.23 7.39±3.52 58.3±8.50 4.53±1.82 对照组 60 85.36±15.25 75.1±9.30 8.01±1.42 4.26±2.84 69.1±9.50 4.88±1.96 t 9.18 25.618 10.887 5.343 15.625 5.38 P < 0.05 < 0.05 < 0.05 < 0.05 < 0.05 >0.05
下载: 导出CSV
表 3 两组患者手术并发症发生比例比较
组别 例数 神经损伤 旁腺损伤 感染 对照组 60 3(5.00) 3(5.00) 2(3.33) 实验组 60 1(1.67) 1(1.67) 0(0.00)
下载: 导出CSV
表 4 两组患者医保指标比较
x±s 组别 例数 总费用/万元 自付比例/% 耗材比例/% 对照组 60 1.232±0.767 23.79±3.84 33.19±6.99 实验组 60 1.212±0.797 23.75±3.84 33.45±6.28
下载: 导出CSV
-
[1] 中国抗癌协会甲状腺癌专业委员会(CATO). 甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版)[J]. 中国肿瘤临床, 2016, 43(10): 405-411. doi: 10.3969/j.issn.1000-8179.2016.10.001
[2] Ancker OV, Krüger M, Wehland M, et al. Multikinase inhibitor treatment in thyroid cancer[J]. Int J Mol Sci, 2019, 21(1): 1-20. doi: 10.3390/ijms21010001
[3] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019, 69(1): 7-34. doi: 10.3322/caac.21551
[4] 孙可欣, 郑荣寿, 张思维, 等. 2015年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2019, 28(1): 1-11. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHLU201901001.htm
[5] Dideban S, Abdollahi A, Meysamie A, et al. Thyroid papillary microcarcinoma: etiology, clinical, manifestations diagnosis, followup, histopathology and prognosis[J]. Iran J Pathol, 2016, 11(1): 1-19.
[6] 陈茂山, 李芳芳, 杨宏伟, 等. 甲状腺微小乳头状癌外科手术方式趋势及相关因素分析: 基于SEER数据库的回顾性研究[J]. 现代肿瘤医学, 2020, 28(24): 4247-4251. doi: 10.3969/j.issn.1672-4992.2020.24.007
[7] Chen JF, Cao J, Qiu FQ, et al. The Efficacy and the safety of ultrasound-guided ablation therapy for treating papillary thyroid microcarcinoma[J]. J Cancer, 2019, 10(21): 5272-5282. doi: 10.7150/jca.36289
[8] Zhang Y, Zhang MB, Luo YK, et al. Effect of chronic lymphocytic thyroiditis on the efficacy and safety of ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma[J]. Cancer Med, 2019, 8(12): 5450-5458. doi: 10.1002/cam4.2406
[9] 秦嘉黎, 张莎莎, 李刚, 等. 高频超声和超声引导下细针穿刺在诊断甲状腺微小乳头状癌中的价值比较[J]. 临床耳鼻咽喉头颈外科杂志, 2021, 35(8): 718-723. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH202108010.htm
[10] Baek JH, Na DG, Park HS. RE: Management of Low-Risk Papillary Thyroid Microcarcinoma[J]. Korean J Radiol, 2017, 18(2): 408-409. doi: 10.3348/kjr.2017.18.2.408
[11] Liu LS, Liang J, Li JH, et al. The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis[J]. Eur Arch Otorhinolaryngol, 2017, 274(3): 1327-1338. doi: 10.1007/s00405-016-4302-0
[12] 朱精强, 苏平安. 理性思辨: 甲状腺微小乳头状癌的诊治策略[J]. 中国普通外科杂志, 2017, 26(5): 547-550. https://www.cnki.com.cn/Article/CJFDTOTAL-ZPWZ201705002.htm
[13] Sapuppo G, Tavarelli M, Belfiore A, et al. Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes[J]. J Clin Endocrinol Metab, 2019, 104(2): 258-265. doi: 10.1210/jc.2018-01383
[14] 邱燕如, 戴毅君, 戴炀斌. 微卫星不稳定及免疫治疗在分化型甲状腺癌中的研究进展[J]. 中国肿瘤临床, 2020, 47(23): 1236-1241. doi: 10.3969/j.issn.1000-8179.2020.23.109
[15] Ayubi E, Sullman MJM, Safiri S. Re: "Dynamic Risk Stratification for Predicting Recurrence in Patients With Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy" by Park et al. : (Thyroid 2017;27: 524-530)[J]. Thyroid, 2017, 27(12): 1582. doi: 10.1089/thy.2017.0303
[16] 安祥, 余丹, 李兵. 预防性中央区淋巴结清扫对甲状腺微小乳头状癌患者预后影响的Meta分析[J]. 临床耳鼻咽喉头颈外科杂志, 2019, 33(2): 138-142. doi: 10.13201/j.issn.1001-1781.2019.02.011
[17] 陆一丹, 时开元, 欧笛, 等. 甲状腺微小癌预后风险评估与治疗决策的研究进展[J]. 中国肿瘤, 2020, 29(12): 962-969. doi: 10.11735/j.issn.1004-0242.2020.12.A013
-
图(1)
表(4)
计量
- 文章访问数: 684
- PDF下载数: 158
- 施引文献: 0